Cargando…

IgG subclass antibodies to human and bacterial HSP60 are not associated with disease activity and progression over time in axial spondyloarthritis

INTRODUCTION: Spondyloarthritis (SpA), an interrelated group of rheumatic diseases, has been suggested to be triggered by bacterial infections prior to the development of an autoimmune response that causes inflammation of the spinal and peripheral joints. Because human heat shock protein 60 (HSP60),...

Descripción completa

Detalles Bibliográficos
Autores principales: Carlsen, Thomas Gelsing, Hjelholt, Astrid, Jurik, Anne Grethe, Schiøttz-Christensen, Berit, Zejden, Anna, Christiansen, Gunna, Deleuran, Bent, Birkelund, Svend
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060232/
https://www.ncbi.nlm.nih.gov/pubmed/23705835
http://dx.doi.org/10.1186/ar4234
_version_ 1782321343924011008
author Carlsen, Thomas Gelsing
Hjelholt, Astrid
Jurik, Anne Grethe
Schiøttz-Christensen, Berit
Zejden, Anna
Christiansen, Gunna
Deleuran, Bent
Birkelund, Svend
author_facet Carlsen, Thomas Gelsing
Hjelholt, Astrid
Jurik, Anne Grethe
Schiøttz-Christensen, Berit
Zejden, Anna
Christiansen, Gunna
Deleuran, Bent
Birkelund, Svend
author_sort Carlsen, Thomas Gelsing
collection PubMed
description INTRODUCTION: Spondyloarthritis (SpA), an interrelated group of rheumatic diseases, has been suggested to be triggered by bacterial infections prior to the development of an autoimmune response that causes inflammation of the spinal and peripheral joints. Because human heat shock protein 60 (HSP60), recently renamed HSPD1, and bacterial HSP60 are highly homologous, immunological cross-reactivity has been proposed as a mechanism of disease initiation. However, previous investigations of the humoral immune response to HSP60 in SpA patients have lacked determination of immunoglobulin G (IgG) subclasses and patient follow-up. In this study, we have focused on these parameters in a cohort of axial SpA patients with a well-established set of clinical characteristics, including MRI changes and human leukocyte antigen B27. METHODS: IgG subclass antibodies (IgG1, IgG2, IgG3 and IgG4) against recombinant HSP60 of three reactive arthritis-related bacteria; human HSP60; and the microorganisms Chlamydia trachomatis and C. pneumoniae were determined by ELISA. Serum samples collected from 2004 to 2006 and in 2010 and 2011 from 39 axial SpA patients were analyzed and compared with samples from 39 healthy controls. The Mann-Whitney U test and Wilcoxon matched pairs test were used to compare the antibody levels in different and paired groups, respectively. P < 0.01 was considered significant. The Spearman nonparametric correlation was used to determine correlation between antibody levels and between antibody levels and the disease parameters. RESULTS: Elevated levels of IgG1 and IgG3 to human HSP60 and IgG1 to HSP60 of Salmonella enterica Enteritidis were observed in SpA patients compared with healthy controls at both time points. The antibody levels were almost constant over time for IgG1, whereas high levels of IgG3 to human HSP60 tended to decrease over time. The antibody response to human HSP60 was predominantly of the IgG3 subclass, and patients with high levels of IgG3 to this antigen had low levels of IgG1, indicating an inverse association. Different IgG subclasses were produced against bacterial and human HSP60 in the same serum sample, IgG1 and IgG3, respectively, indicating that there was no cross-reaction. CONCLUSIONS: A significant association was observed between axial SpA and the presence of IgG1/IgG3 antibodies to human HSP60 and of IgG1 to S. enterica Enteritidis and C. trachomatis. Generation of antibodies to human HSP60 was independent of the presence of antibodies to bacterial HSP60. No association was observed between clinical and MRI changes with antibodies over time. Altogether, such antibodies do not reflect the disease activity in these patients. This study has been approved by the Regional Research Ethics Committee of Central Jutland, Denmark. Trial registration numbers: 20050046 and 20100083
format Online
Article
Text
id pubmed-4060232
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40602322014-06-17 IgG subclass antibodies to human and bacterial HSP60 are not associated with disease activity and progression over time in axial spondyloarthritis Carlsen, Thomas Gelsing Hjelholt, Astrid Jurik, Anne Grethe Schiøttz-Christensen, Berit Zejden, Anna Christiansen, Gunna Deleuran, Bent Birkelund, Svend Arthritis Res Ther Research Article INTRODUCTION: Spondyloarthritis (SpA), an interrelated group of rheumatic diseases, has been suggested to be triggered by bacterial infections prior to the development of an autoimmune response that causes inflammation of the spinal and peripheral joints. Because human heat shock protein 60 (HSP60), recently renamed HSPD1, and bacterial HSP60 are highly homologous, immunological cross-reactivity has been proposed as a mechanism of disease initiation. However, previous investigations of the humoral immune response to HSP60 in SpA patients have lacked determination of immunoglobulin G (IgG) subclasses and patient follow-up. In this study, we have focused on these parameters in a cohort of axial SpA patients with a well-established set of clinical characteristics, including MRI changes and human leukocyte antigen B27. METHODS: IgG subclass antibodies (IgG1, IgG2, IgG3 and IgG4) against recombinant HSP60 of three reactive arthritis-related bacteria; human HSP60; and the microorganisms Chlamydia trachomatis and C. pneumoniae were determined by ELISA. Serum samples collected from 2004 to 2006 and in 2010 and 2011 from 39 axial SpA patients were analyzed and compared with samples from 39 healthy controls. The Mann-Whitney U test and Wilcoxon matched pairs test were used to compare the antibody levels in different and paired groups, respectively. P < 0.01 was considered significant. The Spearman nonparametric correlation was used to determine correlation between antibody levels and between antibody levels and the disease parameters. RESULTS: Elevated levels of IgG1 and IgG3 to human HSP60 and IgG1 to HSP60 of Salmonella enterica Enteritidis were observed in SpA patients compared with healthy controls at both time points. The antibody levels were almost constant over time for IgG1, whereas high levels of IgG3 to human HSP60 tended to decrease over time. The antibody response to human HSP60 was predominantly of the IgG3 subclass, and patients with high levels of IgG3 to this antigen had low levels of IgG1, indicating an inverse association. Different IgG subclasses were produced against bacterial and human HSP60 in the same serum sample, IgG1 and IgG3, respectively, indicating that there was no cross-reaction. CONCLUSIONS: A significant association was observed between axial SpA and the presence of IgG1/IgG3 antibodies to human HSP60 and of IgG1 to S. enterica Enteritidis and C. trachomatis. Generation of antibodies to human HSP60 was independent of the presence of antibodies to bacterial HSP60. No association was observed between clinical and MRI changes with antibodies over time. Altogether, such antibodies do not reflect the disease activity in these patients. This study has been approved by the Regional Research Ethics Committee of Central Jutland, Denmark. Trial registration numbers: 20050046 and 20100083 BioMed Central 2013 2013-05-25 /pmc/articles/PMC4060232/ /pubmed/23705835 http://dx.doi.org/10.1186/ar4234 Text en Copyright © 2013 Carlsen et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Carlsen, Thomas Gelsing
Hjelholt, Astrid
Jurik, Anne Grethe
Schiøttz-Christensen, Berit
Zejden, Anna
Christiansen, Gunna
Deleuran, Bent
Birkelund, Svend
IgG subclass antibodies to human and bacterial HSP60 are not associated with disease activity and progression over time in axial spondyloarthritis
title IgG subclass antibodies to human and bacterial HSP60 are not associated with disease activity and progression over time in axial spondyloarthritis
title_full IgG subclass antibodies to human and bacterial HSP60 are not associated with disease activity and progression over time in axial spondyloarthritis
title_fullStr IgG subclass antibodies to human and bacterial HSP60 are not associated with disease activity and progression over time in axial spondyloarthritis
title_full_unstemmed IgG subclass antibodies to human and bacterial HSP60 are not associated with disease activity and progression over time in axial spondyloarthritis
title_short IgG subclass antibodies to human and bacterial HSP60 are not associated with disease activity and progression over time in axial spondyloarthritis
title_sort igg subclass antibodies to human and bacterial hsp60 are not associated with disease activity and progression over time in axial spondyloarthritis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060232/
https://www.ncbi.nlm.nih.gov/pubmed/23705835
http://dx.doi.org/10.1186/ar4234
work_keys_str_mv AT carlsenthomasgelsing iggsubclassantibodiestohumanandbacterialhsp60arenotassociatedwithdiseaseactivityandprogressionovertimeinaxialspondyloarthritis
AT hjelholtastrid iggsubclassantibodiestohumanandbacterialhsp60arenotassociatedwithdiseaseactivityandprogressionovertimeinaxialspondyloarthritis
AT jurikannegrethe iggsubclassantibodiestohumanandbacterialhsp60arenotassociatedwithdiseaseactivityandprogressionovertimeinaxialspondyloarthritis
AT schiøttzchristensenberit iggsubclassantibodiestohumanandbacterialhsp60arenotassociatedwithdiseaseactivityandprogressionovertimeinaxialspondyloarthritis
AT zejdenanna iggsubclassantibodiestohumanandbacterialhsp60arenotassociatedwithdiseaseactivityandprogressionovertimeinaxialspondyloarthritis
AT christiansengunna iggsubclassantibodiestohumanandbacterialhsp60arenotassociatedwithdiseaseactivityandprogressionovertimeinaxialspondyloarthritis
AT deleuranbent iggsubclassantibodiestohumanandbacterialhsp60arenotassociatedwithdiseaseactivityandprogressionovertimeinaxialspondyloarthritis
AT birkelundsvend iggsubclassantibodiestohumanandbacterialhsp60arenotassociatedwithdiseaseactivityandprogressionovertimeinaxialspondyloarthritis